Gefarnate

吉法酯

Report date: 2023/02/21 20:00:25
NME

Base Information

Drug NameGefarnate
Drug Alias Namegefarnato合欢香叶酯gefarnatumDE-099DA-688
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMucin stimulants
TargetsMucin
Therapy Area/IndicationsStomach UlcerDuodenal UlcerPeptic Ulcer +[4] 
Global Approved IndicationsStomach UlcerDuodenal Ulcer
Approved Indications in ChinaStomach UlcerDuodenal Ulcer
Original Approved Country/TerritoryMainland China
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesSeiko Eiyo Yakuhin Co Ltd
Inactive CompaniesN/A
Active IndicationsStomach UlcerDuodenal UlcerPeptic Ulcer +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeA02BX07
Related LinksWikipediaKEGG